Advertisement

Topics

Latest Endocrinology NewsRSS

06:48 EDT 26th September 2017 | BioPortfolio

Novo Nordisk now hiring for new manufacturing facility in New Hampshire

WEST LEBANON, N.H., Oct. 29, 2014 /PRNewswire/ -- Novo Nordisk, a global pharmaceutical company that produces medicines for patients with diabetes, hemophilia or growth-related disorders, announced plans to hire up to 90 people at its newly-acquired manufacturing plant in West Lebanon, NH. The facility was formerly owned by Olympus Biotech. The facility will produce products for the tre...

Texas Children's Hospital ranks 4th among nation's best pediatric institutions by U.S.News & World Report

Newborn, heart, digestive disorders and pulmonology all top ranked subspecialties HOUSTON, June 5, 2012 /PRNewswire-USNewswire/ -- Texas Children's Hospital has once again been named as a national leader among pediatric hospitals in U.S.News & World Report's 2012-13 edition of Best Children's Hospitals. Ranked 4th among all children's hospitals nationally and one of only 12 hospitals...

PROLOR Biotech to Host Investor Conference Call

NES-ZIONA, Israel, Aug. 24, 2011 /PRNewswire/ -- PROLOR Biotech, Inc. (NYSE Amex: PBTH), a clinical stage company developing next generation biobetter therapeutic proteins, today announced that company management will host an investor conference call and webcast on September 7, 2011 to review recently announced corporate developments, including the positive results from the company's Phase II tria...

Women endocrinologists must ‘lead from where you stand’

Although women are underrepresented in leadership positions across medicine, those in endocrinology are seeing more opportunities as their numbers increase. “As more women enter medicine, we are seeing pronounced gender segregation in specialty choice — some specialties are becoming female-predominant, while others continue to attract mostly men,” Elaine M. Pelley, MD, of the division of end...

Global Follicle Stimulating Hormone Market Data Survey Report 2025 [Report Updated: 08092017] Prices from USD $1500

SummaryFollicle stimulating hormone FSH is a hormone made by the pituitary gland that affects the gonads female ovaries and males testes. In females, it stimulates growth of the ovarian follicles.The global Follicle Stimulating Hormone market will reach xxx Million USD in 2017 with CAGR xx% 20182025. The main contents of the report including:Global market size and forecastRegional market size, pro...

M.D. Science Lab Launches BioXgenic 12 Hour X-Treme Testosterone Booster With Unique Prostate Protection Advancement

POMPANO BEACH, Fla., Sept. 25, 2017 /PRNewswire/ -- Health and wellness industry leader M.D. Science Lab announced today the official launch of the company's highly-anticipated new product - BioXgenic 12 Hour X-Treme natural testosterone booster. The innovative new men's nutritional supplement, which uses liquid capsule technology, is the most advanced testosterone booster on the market ...

Report: Exhausted Employees Cost American Companies Millions of Dollars Annually

INDIANAPOLIS, Sept. 25, 2017 /PRNewswire-USNewswire/ -- Sleep disorders and sleep deficiency are hidden workplace issues that affect employers across America. New research from the National Safety Council and the Brigham Health Sleep Matters Initiative reveals that a U.S.  employer with 1,000 workers stands to lose about $1.4 million each year in absenteeism, diminished productivity, and heal...

Conferenceseries is Glad to Announce Its 4th International Conference on Spine and Spinal Disorders Scheduled on September 13-14, 2018 at Prague, Czech Republic

Prague, Czech Republic, September 25, 2017 --(PR.com)-- 4th International Conference on Spine and Spinal Disorders scheduled on September 13-14, 2018 at Prague, Czech Republic. Spine Conference will be organized around the theme “Exploring innovations for a better robust Spine health.” This is a unique platform which aims to generate new ideas for treatment and management of Spine and...

Initial Results of the eShunt System Presented at the International Society of Hydrocephalus and Cerebrospinal Fluid Disorders Annual Meeting in Kobe, Japan

BOSTON, Sept. 25, 2017 /PRNewswire/ -- CereVasc, LLC, a company focused on improving the care of patients with communicating hydrocephalus announced today the presentation of early test data of its eShunt System at the annual meeting of experts in hydrocephalus diagnosis and treatment held in Kobe, Japan.  The podium presentation by Adel Malek, M.D., Ph.D., Director of Neuro-interventional Su...

Viking Therapeutics to Host Key Opinion Leader Event to Discuss Musculoskeletal Therapeutics in Hip Fracture and Other Settings

SAN DIEGO, Sept. 25, 2017 /PRNewswire/ -- Viking Therapeutics, Inc. ("Viking") (NASDAQ: VKTX), a clinical-stage biopharmaceutical company focused on the development of novel therapies for metabolic and endocrine disorders, today announced that it will host a key opinion leader (KOL) presentation and webcast to highlight the current unmet need in post-fracture therapy and discuss the company's lead...

Ocugen Announces FDA Acceptance of Investigational New Drug Application for OCU310 (brimonidine/steroid combination therapy) and Initiates Proof of Concept Study for Treatment of Dry Eye Disease

MALVERN, Pa., Sept. 25, 2017 /PRNewswire/ -- Ocugen, Inc., a clinical stage biopharmaceutical company developing novel treatments for sight-threatening diseases, today announced that the U.S. Food and Drug Administration (FDA) accepted its Investigational New Drug (IND) application for OCU310 (brimonidine/steroid combination therapy), a topical formulation for the treatment of dry eye disease...

Omeros to Present at Deutsche Bank Securities Health Care Conference

SEATTLE, May 2, 2012 /PRNewswire/ -- Omeros Corporation (NASDAQ: OMER), a biopharmaceutical company committed to discovering, developing and commercializing products focused on inflammation, bleeding and disorders of the central nervous system, today announced that Gregory A. Demopulos, M.D., chairman and chief executive officer, is scheduled to present at the Deutsche Bank Securities 37th Annual ...

Self-Grooming Disorders: Separate Entities or a Single Category?

Trichotillomania, excoriation, and nail biting may be manifestations of a single underlying tendency.

Effects of Discontinuing Antidepressants in Patients with Anxiety Disorders

Discontinuation increased relapse risk threefold, but clinical moderators or treatment mediators of this increased risk remain unknown.

Omeros to Present at BioCentury Future Leaders in the Biotech Industry Conference

SEATTLE, March 21, 2014 /PRNewswire/ -- Omeros Corporation (NASDAQ: OMER), a biopharmaceutical company committed to discovering, developing and commercializing products focused on inflammation, bleeding and disorders of the central nervous system, today announced that Gregory A. Demopulos, M.D., chairman and chief executive officer, will present at the BioCentury Future Leaders in the Biotech...

Retinoic Acid Receptor Beta RAR Beta or HBV Activated Protein or Nuclear Receptor Subfamily 1 Group B Member 2 or RAR Epsilon or NR1B2 or RARB Pipeline Review, H2 2017 [Report Updated: 19092017] Prices from USD $3500

Retinoic Acid Receptor Beta RAR Beta or HBV Activated Protein or Nuclear Receptor Subfamily 1 Group B Member 2 or RAR Epsilon or NR1B2 or RARB Pipeline Review, H2 2017SummaryRetinoic Acid Receptor Beta RAR Beta or HBV Activated Protein or Nuclear Receptor Subfamily 1 Group B Member 2 or RAR Epsilon or NR1B2 or RARB Retinoic acid receptor beta RARB is a nuclear receptor that is encoded by the RAR...

Alpha Antitrypsin Deficiency Pipeline Review, H2 2017 [Report Updated: 22082017] Prices from USD $2000

Alpha Antitrypsin Deficiency Pipeline Review, H2 2017SummaryGlobal Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Alpha Antitrypsin Deficiency Pipeline Review, H2 2017, provides an overview of the Alpha Antitrypsin Deficiency Genetic Disorders pipeline landscape.Alphaantitrypsin deficiency is an inherited disease that occurs due to lack of alpha1 antitrypsin AAT, a ...

Garvan Institute of Medical Research Pharmaceuticals Healthcare Deals and Alliances Profile [Report Updated: 28082017] Prices from USD $250

SummaryGarvan Institute of Medical Research Garvan Institute is a biomedical institute that offers research services. The institute conducts research in the fields of cancer, diabetes and obesity, Alzheimer's and Parkinson's disease, asthma, rheumatoid arthritis, osteoporosis, arthritis and pituitary disorders. It also conducts research in different types of cancer such as breast cancer, prostate ...

Transdermal Drug Delivery Technologies, Markets, and Companies [Report Updated: 08092017] Prices from USD $3500

Benefits of this reportUptodate onestop information on transdermal drug deliveryDescription of 110 companies involved and 110 collaborations in this areaMarket analysis 20152025/Market values in major regionsStrategies for developing markets for transdermal drug deliveryA selected bibliography of 220 publicationsText is supplemented by 22 tables and 14 figuresWho should read this report?Biotechnol...

Bristol-Myers Squibb’s Opdivo® (nivolumab) Receives FDA Approval for the Treatment of Hepatocellular Carcinoma Patients Previously Treated with Sorafenib

Opdivo is the first and only Immuno-Oncology agent to receive this FDA approval; this accelerated approval is based on tumor response rate and durability of response in these patients The CheckMate -040 pivotal study evaluated Opdivo in patients with and without active Hepatitis B or C infection, and across PD-L1 expression ...

Sage Therapeutics to Participate in Leerink Investor Conference

Sage Therapeutics (NASDAQ: SAGE), a clinical-stage biopharmaceutical company developing novel medicines to treat life-altering central nervous system (CNS) disorders, today announced that the Company will participate in the Leerink Partners Rare Disease Roundtable on Wednesday, September 27, 2017, with a presentation at 2:00 p.m. ET in New York, NY. ...

Testosterone Test Volume and Sales Forecasts 2021: US, Europe, JapanHospitals, Commercial Labs, POC Locations [Report Updated: 15092017] Prices from USD $750

This new report from LeadingMarketResearch provides analysis of Testosterone testing, including clinical significance, current and emerging diagnostic procedures, as well as test volume and sales forecasts by country and market segment. Geographic CoverageFrance, Germany, Italy, Japan, Spain, UK, USAMarket Segmentation Centralized Testing Hospitals Commercial/Private LaboratoriesPOC/Decentralized ...

AbbVie and Bristol-Myers Squibb Announce Clinical Research Collaboration to Evaluate a Therapeutic Regimen in Advanced Solid Tumors

AbbVie (NYSE: ABBV) and Bristol-Myers Squibb Company (NYSE: BMY) today announced a clinical trial collaboration to evaluate the combinat

Versartis crashes after Phase 3 miss

Friday's setback throws the biotech's plans to bring a long-acting human growth hormone to market into doubt.

Japan Ministry of Health, Labor and Welfare Approves Opdivo (nivolumab) for the Treatment of Patients with Unresectable Advanced or Recurrent Gastric Cancer Which Has Progressed After Chemotherapy

Opdivo is the first and only Immuno-Oncology treatment to demonstrate survival benefit in patients who underwent two or more prior treatments Opdivo is the first Immuno-Oncology agent anywhere in the world to receive approval for unresectable advanced or recurrent gastric cancer based on a Phase 3 study Bristol-Myers

Quick Search
Advertisement
 

review and buy Endocrinology market research data and corporate reports here